The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
5 Biggest Blockchain ETFs in 2025
next post
Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

Van Eck Opposes Equinox Gold’s US$1.8 Billion Takeover...

March 20, 2025

Zodiac Gold Announces Conversion of Reconnaissance License into...

September 17, 2024

C29 Metals Limited (ASX: C29) – Trading Halt

October 16, 2024

Crypto Market Update: Trump Demands Swift Passage of...

March 7, 2026

Canadian Investment Regulatory Organization Trade Resumption – SRR

February 8, 2025

Appendix 4D and Half Yearly Accounts

February 27, 2025

Tech Weekly: CES Announcements Reignite Memory Shortage Concerns

January 11, 2026

Jeff Clark: Juniors “Dramatically Oversold,” is This a...

November 15, 2023

Fortune Minerals Announces U.S. Government Funding to Accelerate...

May 17, 2024

5 Top Canadian Silver Stocks of 2025

February 14, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,627)
    • Investing (5,287)
    • Politics (7,046)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved